Aptahem AB (publ) (NGM:APTA)
Sweden · Delayed Price · Currency is SEK 0.3440
+0.0290 (9.21%)
At close: Sep 24, 2026
Aptahem AB Market Cap
Aptahem AB has a market cap or net worth of 8.17 million as of September 24, 2026. Its market cap has decreased by -70.43% in one year.
Market Cap
8.17M
Enterprise Value
6.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.34
ChartMarket Cap Chart
Since April 17, 2015, Aptahem AB's market cap has decreased from 51.10M to 8.17M, a decrease of -84.01%. That is a compound annual growth rate of -14.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 8.17M | -65.98% |
| Dec 30, 2025 | 24.01M | 35.28% |
| Dec 30, 2024 | 17.75M | -4.71% |
| Dec 29, 2023 | 18.63M | -73.52% |
| Dec 30, 2022 | 70.35M | -20.14% |
| Dec 30, 2021 | 88.10M | -5.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annexin Pharmaceuticals AB | 69.89M |
| AcouSort AB | 63.07M |
| Modus Therapeutics Holding AB | 58.29M |
| OncoZenge AB | 51.87M |
| Magle Chemoswed Holding AB | 50.84M |
| Fluicell AB | 41.62M |
| ExpreS2ion Biotech Holding AB | 28.02M |
| Alligator Bioscience AB | 12.69M |